EUVIMEDEUVIMED entdecken
Open Access

Mapping the Final Journey: End‐Of‐Life Frailty Trajectories and Cause of Death

Mapping the Final Journey: End-of-Life-Frailty-Trajektorien und Todesursache

Jianhong Xu, Jonathan Ka-Long Mak iD, Qian-Li Xue, Chenkai Wu iD

Journal of the American Geriatrics Society · 2025-09 · 73 (9) · 2695-2706

DOI: 10.1111/jgs.19567 ↗

Auf einen Blick

In der UK Biobank wurden Frailty-Verläufe im letzten Lebensjahr untersucht. Bei neurodegenerativen Erkrankungen zeigten sich häufiger schwere und stabile Frailty-Trajektorien.

Fragestellung

Wie verlaufen Frailty-Trajektorien im letzten Lebensjahr und unterscheiden sie sich nach der Todesursache?

Methode

Analyse von Verknüpfungsdaten nationaler Todesregister der UK Biobank; monatliche HFRS-Werte 1 Jahr vor dem Tod; Latent-Class-Trajectory-Modelle und multinomiale logistische Regression.

Ergebnisse

37.465 Verstorbene. Bei 2.895 (7,7 %) mit neurodegenerativen Krankheiten: rasch progrediente Frailty 6,9 %, moderate Progression 21,1 %, fortgeschrittene und stabile Frailty 72,0 %. Andere Todesursachen: 24,7 %, 46,5 %, 28,8 %.

Schlussfolgerung der Autor:innen

Die Frailty-Trajektorien am Lebensende unterschieden sich nach Todesursache; bei neurodegenerativen Erkrankungen war die Frailty schwerer ausgeprägt.

Kernaussagen

  • 37.465 Verstorbene aus der UK Biobank
  • Drei Frailty-Trajektorien im letzten Lebensjahr
  • Neurodegenerative Krankheiten: häufiger fortgeschrittene, stabile Frailty

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Geriatrics Society, online erschienen am 06.06.2025. Verfasst von Jianhong Xu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Global Health Research Center, Duke Kunshan University, Kunshan, China. Hauptthemen laut MEDLINE: Frailty, Frail Elderly, Terminal Care. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS.

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Frailty changes associated with aging have been well‐documented in existing research. However, there is limited evidence on how frailty progresses during the end‐of‐life stage. We aimed to explore trajectories of frailty in the last year of life and explore how the distribution of these trajectories differs according to the conditions leading to death.

Methods

Based on national death registries linkage data in the UK Biobank, 37,465 decedents were included in the analytic sample. Monthly frailty scores were obtained for 1 year prior to death using the Hospital Frailty Risk Score (HFRS; a cumulative deficit measure of frailty). Latent class trajectory models were used to estimate trajectories of frailty. We further analyzed the distribution of these frailty trajectories across different conditions leading to death. Multinomial logistic regression models were applied to examine the associations between predictors and frailty trajectories.

Results

Among 37,465 decedents, 2895 (7.7%) died from neurodegenerative diseases. Three distinct frailty trajectories were identified among these decedents: rapidly progressive frailty (6.9%), moderate progression of frailty (21.1%), and advanced and stable frailty (72.0%). These patterns differed significantly from those observed in decedents with other causes of death, who exhibited persistently low frailty (24.7%), intermediate and progressive frailty (46.5%), and advanced and progressive frailty (28.8%). Compared to cancer decedents, individuals with neurodegenerative diseases had higher baseline frailty and a dominant trajectory of advanced and stable frailty. Older age, lower education, and greater chronic disease burden were associated with the advanced and progressive frailty trajectory.

Conclusions

Frailty trajectories at the end of life varied by cause of death, with neurodegenerative disease decedents exhibiting more severe frailty. These findings underscored the need for early identification of frailty and tailored end‐of‐life care strategies, particularly for individuals with neurodegenerative diseases who often experienced prolonged and severe frailty.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FrailtyFrail ElderlyTerminal CareHumansFemaleMaleAgedCause of DeathAged, 80 and overUnited KingdomRegistriesGeriatric AssessmentDisease Progression

Stichwörter der Autor:innen

cause of deathend‐of‐lifefrailtytrajectory

Autor:innen und Institutionen

  • Global Health Research Center, Duke Kunshan University, Kunshan, China.
  • Department of Pharmacology and Pharmacy, The University of Hong Kong, Hong Kong, China.
  • Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • Department of Medicine Division of Geriatric Medicine and Gerontology, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
  • Center on Aging and Health, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA.

ORCID-Profile: Jonathan Ka-Long Mak, Chenkai Wu

Förderung

  • NIA NIH HHS

Zitieren

APA

Xu, J., Mak, J. K., Xue, Q. L., & Wu, C. (2025). Mapping the Final Journey: End‐Of‐Life Frailty Trajectories and Cause of Death. Journal of the American Geriatrics Society, 73(9), 2695-2706. https://doi.org/10.1111/jgs.19567

Vancouver

Xu J, Mak JK, Xue QL, Wu C. Mapping the Final Journey: End‐Of‐Life Frailty Trajectories and Cause of Death. Journal of the American Geriatrics Society. 2025;73(9):2695-2706. doi:10.1111/jgs.19567

BibTeX
@article{Xu2025,
  author = {Xu, Jianhong and Mak, Jonathan Ka-Long and Xue, Qian-Li and Wu, Chenkai},
  title = {Mapping the Final Journey: End‐Of‐Life Frailty Trajectories and Cause of Death},
  journal = {Journal of the American Geriatrics Society},
  year = {2025},
  volume = {73},
  number = {9},
  pages = {2695--2706},
  doi = {10.1111/jgs.19567}
}
Kostenlos starten →